Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03975647 |
|---|---|
| Brief Title: | A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer |
| First Submitted : | June 4, 2019 |
| First Submitted that Met QC Criteria : | June 4, 2019 |
| First Posted : | June 5, 2019 |
| Last Update Submitted that Met QC Criteria : | May 3, 2024 |
| Last Update Posted : | May 7, 2024 |